Unknown

Dataset Information

0

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area.


ABSTRACT: We report very low SARS-CoV-2 seroprevalence in two San Francisco Bay Area populations. Seropositivity was 0.26% in 387 hospitalized patients admitted for non-respiratory indications and 0.1% in 1,000 blood donors. We additionally describe the longitudinal dynamics of immunoglobulin-G, immunoglobulin-M, and in vitro neutralizing antibody titers in COVID-19 patients. Neutralizing antibodies rise in tandem with immunoglobulin levels following symptom onset, exhibiting median time to seroconversion within one day of each other, and there is >93% positive percent agreement between detection of immunoglobulin-G and neutralizing titers.

SUBMITTER: Ng DL 

PROVIDER: S-EPMC7273245 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area.

Ng Dianna L DL   Goldgof Gregory M GM   Shy Brian R BR   Levine Andrew G AG   Balcerek Joanna J   Bapat Sagar P SP   Prostko John J   Rodgers Mary M   Coller Kelly K   Pearce Sandy S   Franz Sergej S   Du Li L   Stone Mars M   Pillai Satish K SK   Sotomayor-Gonzalez Alicia A   Servellita Venice V   Martin Claudia Sanchez San CSS   Granados Andrea A   Glasner Dustin R DR   Han Lucy M LM   Truong Kent K   Akagi Naomi N   Nguyen David N DN   Neumann Neil M NM   Qazi Daniel D   Hsu Elaine E   Gu Wei W   Santos Yale A YA   Custer Brian B   Green Valerie V   Williamson Phillip P   Hills Nancy K NK   Lu Chuanyi M CM   Whitman Jeffrey D JD   Stramer Susan S   Wang Candace C   Reyes Kevin K   Hakim Jill M C JMC   Sujishi Kirk K   Alazzeh Fariba F   Pham Lori L   Oon Ching-Ying CY   Miller Steve S   Kurtz Theodore T   Hackett John J   Simmons Graham G   Busch Michael P MP   Chiu Charles Y CY  

medRxiv : the preprint server for health sciences 20200525


We report very low SARS-CoV-2 seroprevalence in two San Francisco Bay Area populations. Seropositivity was 0.26% in 387 hospitalized patients admitted for non-respiratory indications and 0.1% in 1,000 blood donors. We additionally describe the longitudinal dynamics of immunoglobulin-G, immunoglobulin-M, and in vitro neutralizing antibody titers in COVID-19 patients. Neutralizing antibodies rise in tandem with immunoglobulin levels following symptom onset, exhibiting median time to seroconversion  ...[more]

Similar Datasets

| S-EPMC7499171 | biostudies-literature
| S-EPMC8325558 | biostudies-literature
| S-EPMC7263601 | biostudies-literature
| S-EPMC6433244 | biostudies-literature
| S-EPMC6616964 | biostudies-literature
| S-EPMC4944708 | biostudies-literature
| S-EPMC8823666 | biostudies-literature
| S-EPMC9212878 | biostudies-literature
| S-EPMC5846283 | biostudies-other
| S-EPMC5033763 | biostudies-literature